The global Difficile-Associated Diarrhea Treatment Market (Clostridioides difficile infection or CDI) is undergoing a major clinical shift in 2026. Long considered a difficult-to-manage byproduct of heavy antibiotic use in healthcare settings, CDI treatment has evolved from simple antibiotic intervention to a sophisticated landscape involving microbiome restoration and targeted biolog... https://www.databridgemarketresearch.com/